MustGrow Biologics Corp. (MGROF)
OTCQB OTCQB Primary 
MustGrow Biologics expands revenue, enhances sales reach through NexusBioAg acquisition, analysts believe
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF)' acquisition of NexusBioAg “dramatically changes” the revenue outlook for the company in 2025, analysts at Noble Capital Markets believe. Last week, the company announced it finalized the acquisition of NexusBio for a cash payment of approximately C$1.6 million and earn-out payments totalling a percentage of gross margin on certain itemized products sold by the company in 2025 and 2026.
MustGrow Biologics CEO discusses NexusBio acquisition and future plans – ICYMI
In a recent Q&A with Proactive, MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson shared insights into the company's transformative acquisition of NexusBio Ag assets from Univar Solutions. The deal brings a seasoned sales and marketing team, an established product line in the biologics and regenerative agriculture space, and a significant revenue stream that propels MustGrow from pre-revenue status.
MustGrow shares surge after NexusBioAg acquisition finalized
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) shares shot higher on Thursday afternoon in heavy trading following its earlier announcement that it had finalized the acquisition of NexusBio. Shares gained nearly 22% in afternoon trading to reach C$1.40 at the close in Toronto.
MustGrow Biologics wraps up NexusBio acuqisition
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) said it has closed the acquisition of crop nutrition company NexusBioAg assets from Univar Solutions Canada Ltd. The acquisition provides MustGrow with a Canadian sales, marketing, and distribution division, with plans to expand operations into the United States.
MustGrow secures $2M private placement, eyes TerraSante production ramp-up
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has announced a proposed non-brokered private placement to raise approximately $2 million in gross proceeds, with an option to increase the offering by an additional $1 million. Proceeds from the private placement will be used for inventory production for TerraSante, its certified biofertility product.
MustGrow Biologics moves to acquire agricultural products firm NexusBioAg
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced it has signed a non-binding term sheet with Univar Solutions Canada Ltd to acquire crop nutrition company NexusBioAg. The move aims to position MustGrow as a fully integrated provider of biological and regenerative agriculture solutions.
MustGrow reports first revenue from TerraSante with major sales ramp-up forecasted for 2025
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) recognized revenue for sales of its biofertility product TerraSante for the first time in the third quarter with higher revenue generation on the horizon, analysts at Noble Capital believe. The agricultural technology company reported revenue of about C$279,000 for Q3, including C$272,000 in deferred revenue.
MustGrow transitions to commercial TerraSante sales, prepares for 2025 ramp-up
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) is advancing its transition from research and development to commercialization with key developments across its biofertility and biopesticide products, the company said in a 2024 pipeline update. The company has begun manufacturing and selling its TerraSante biofertility product in the US, having secured regulatory approvals in important agricultural states such as California, Florida, and Oregon.
MustGrow secures funding for mustard seed research in collaboration with Agriculture and Agri-Food Canada
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received funding to investigate mustard-derived ingredient opportunities in human and animal health applications from Agriculture and Agri-Food Canada (AAFC). The funding has been provided through the AgriScience Program – Projects Component under the Sustainable Canadian Agriculture Partnership.
MustGrow Biologics COO talks TerraSante's growth into Florida - ICYMI
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) COO, Colin Bletsky, talked with Proactive about the company's recent expansion into Florida with TerraSante, their innovative bio-fertility product. Following the earlier approval for California, Florida represents another significant market for MustGrow, as it is the second-largest region for fruit and vegetable production in the U.S.
MustGrow East Coast expansion eyed by analysts following TerraSante approval in Florida
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has secured approval for its mustard-based biofertility product TerraSante in a sixth state, with analysts at Noble Capital Markets expecting more approvals to come sooner rather than later. The company this week announced it has secured registration approval for TerraSante from the Florida Department of Agriculture and Consumer Services.
MustGrow secures Florida registration for biofertility product TerraSante
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received registration approval for its mustard plant-based organic biofertility product TerraSante from the Florida Department of Agriculture of Consumer Services. The company said the Florida organic certification is included under its existing Organic OMRI Listed certifications in Arizona, Idaho, Oregon and Washington State.
